We would love to hear your thoughts about our site and services, please take our survey here.
Woodford should have kept GSK and dumped PFG instead! Its easy to talk about PFG in hindsight, but Glaxo is too much of a 'strong and stable' share to get rid of it.
we could soon see some reaction here similar to Hikma today
never thought i would be able to buy here at 1476 again!
Buy 1,800.00 Another ambitious target price despite the falling SP...
Buy -1,885.00 They are a bit too ambitious with their target price, over the long run it might be achievable though
Price seems to be going a tick lower and might want to test the 1550 support. Plenty of upside here as long as it holds.
Exactly as you said Spikeyj. However i don't mind picking up the dividend while waiting for the pharma devt to deliver. It shall be a long wait though, so long term play here.
Managed to get just a few more @ 15.6893 hopefully I got the intraday low here - GLA
mixed results, unsure what to make out of them. The market seems to feel the same, with the price going up and down around 1600 after an initial dip. Need to wait perhaps for some analysts recommendations to see where this is going. GLA
I totally agree. On the same boat here, also bought some at 1588 yesterday. Results coming out in a couple of hours, so looking forward!
of the top up was good, but the relative performance of IMB still disappointing. Once again, I would be better off had I bought BATS...
I really do not want to jinx it again, but the recent SP movement looks very promising technically. It seems 696-706 could be on the cards in the next couple of weeks.
Hi moorhey, I have been thinking about it a lot, however i decided to chance a small top up at these levels, to round up my number of shares. Still bought back less shares than what I sold at 40. Reasons for buying were that the valuation is not so demanding now, it looks technically that a trend reversal is possible at these levels (though it can still dip a bit lower first) and the ex dividend in August is also approaching. I am still not overweight here, but around 3400 it is a buy or hold for me. GLA
Did very well to wait here and added just below 1600! Still averaged up as my average is lower, but this is a share I want to increase position in and keep it. Therefore paid 1599.5 which is higher than my latest purchase at 1551 and the highest that I have ever paid for GSK shares. One of the reason for the purchase is that since Oct 2015 the share does higher lows all the time and every dip is at a higher price than the previous one. That looks like a strong uptrend to me, but there is still the resistance at 1720-1750. Once this resistance is broken, then we can go to 1870 and 2000 long term. Of course it might go the other way and start falling, but then I will wait as long as needed to buy more shares at a much lower price. GLA!
Nice to see some sign of life here today :)
Yes indeed and I have also bought myself. However, as markets can remain irrational for longer than anyone can expect, it is still possible that they can push it lower. Still better to buy now than chasing the SP up when the recovery comes - because it will eventually, even if it takes long.
I will be too! However that is a quite ambitious target on the downside. Not very likely to happen, but still there is a small possibility, could be potentially due to brexit/pound crash/potential general market correction etc.
here today. It is now oversold and I regard it as a safe share to park some money. It may have a bit lower to go before it recovers, but I 've been watching it for weeks and was too impatient to wait longer. GLA
In bargain levels now, I like holding this as a hedge to other positions in the portfolio, might consider another top up if it falls further
at the 650's so that I have more shares to trade when this bounces back - it is a matter of time imo because it looks that the share is being pushed down without the company facing serious trouble. I might save some money to top up further at around 620-630 It would look extreme if they push it that low, however I can expect anything from this share